Term Name: cobimetinib
Synonyms: [3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone, cobimetinib, GDC 0973, GDC-0973, GDC0973, RG 7420, RG7420, Xl 518, Xl-518, XL518
Definition: A member of the class of N-acylazetidines obtained by selective formal condensation of the carboxy group of 3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoic acid with the secondary amino group from the azetidine ring of 3-[(2S)-piperidin-2-yl]azetidin-3-ol. An inhibitor of mitogen-activated protein kinase that is used (as its fumarate salt) in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma.
Ontology: ChEBI [CHEBI:90851]  ( EBI )

Relationships
is a type of: aromatic amine difluorobenzene N-acylazetidine organoiodine compound piperidines secondary amino compound tertiary alcohol
has_role: antineoplastic agent EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
inverse is_conjugate_acid_of: cobimetinib(1+)
is_conjugate_base_of: cobimetinib(1+)